Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Interest Expenses (2013 - 2025)

Scynexis' (SCYX) quarterly Interest Expenses came in at $173000.0 in Q1 2025, down 15.61% on a YoY basis from $205000.0 in Q1 2024, and down 18.01% quarter-over-quarter from $211000.0 in Q4 2024.

Analysis

Scynexis (SCYX) Interest Expenses (2013 - 2025) Analysis & Trends

Scynexis (SCYX) has reported Interest Expenses for 12 consecutive years, with $173000.0 the latest figure, recorded in Q1 2025.

  • For the quarter ending Q1 2025, Interest Expenses fell 15.61% year-over-year to $173000.0; the trailing twelve-month figure through Dec 2025 stood at $173000.0 (down 79.06% YoY), and the FY2025 full-year result was $173000.0, down 79.11% from the prior year.
  • Interest Expenses eased to $173000.0 in Q1 2025 per SCYX's latest filing, from $211000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.5 million in Q4 2022 and bottomed at $173000.0 in Q1 2025.
  • Historically, Interest Expenses has averaged $705117.6 across 5 years, with a median of $445000.0 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Interest Expenses surged 394.86% in 2022, then slumped 85.83% in 2024.
  • Over 5 years, Interest Expenses stood at $982000.0 in 2021, then jumped by 55.7% to $1.5 million in 2022, then sank by 85.48% to $222000.0 in 2023, then dropped by 4.95% to $211000.0 in 2024, then retreated by 18.01% to $173000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods registered $173000.0, $211000.0, and $213000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Scynexis 58.41 Mn -56.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 173,000.00
Dec 31, 2024 211,000.00
Sep 30, 2024 213,000.00
Jun 30, 2024 197,000.00
Mar 31, 2024 205,000.00
Dec 31, 2023 222,000.00
Sep 30, 2023 212,000.00
Jun 30, 2023 1.25 Mn
Mar 31, 2023 1.45 Mn
Dec 31, 2022 1.53 Mn
Sep 30, 2022 1.38 Mn
Jun 30, 2022 1.23 Mn
Mar 31, 2022 1.06 Mn
Dec 31, 2021 982,000.00
Sep 30, 2021 1.02 Mn
Jun 30, 2021 445,000.00
Mar 31, 2021 214,000.00
Dec 31, 2020 322,000.00
Sep 30, 2020 330,000.00
Jun 30, 2020 602,000.00